Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.
Gasparini P, Fassan M, Cascione L, Guler G, Balci S, Irkkan C, Paisie C, Lovat F, Morrison C, Zhang J, Scarpa A, Croce CM, Shapiro CL, Huebner K. Gasparini P, et al. Among authors: shapiro cl. PLoS One. 2014 Feb 5;9(2):e88525. doi: 10.1371/journal.pone.0088525. eCollection 2014. PLoS One. 2014. PMID: 24505496 Free PMC article.
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM. Pichiorri F, et al. Among authors: shapiro cl. J Exp Med. 2013 May 6;210(5):951-68. doi: 10.1084/jem.20120950. Epub 2013 Apr 22. J Exp Med. 2013. PMID: 23610125 Free PMC article.
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.
Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, Huebner K, Croce CM. Gasparini P, et al. Among authors: shapiro cl. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4536-41. doi: 10.1073/pnas.1402604111. Epub 2014 Mar 10. Proc Natl Acad Sci U S A. 2014. PMID: 24616504 Free PMC article.
Pluripotent stem cell miRNAs and metastasis in invasive breast cancer.
Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Di Leva G, Gasparini P, Dama P, Marchesini J, Galasso M, Manfrini M, Zerbinati C, Corrà F, Wise T, Wojcik SE, Previati M, Pichiorri F, Zanesi N, Alder H, Palatini J, Huebner KF, Shapiro CL, Negrini M, Vecchione A, Rosenberg AL, Croce CM, Garzon R. Volinia S, et al. Among authors: shapiro cl. J Natl Cancer Inst. 2014 Oct 11;106(12):dju324. doi: 10.1093/jnci/dju324. Print 2014 Dec. J Natl Cancer Inst. 2014. PMID: 25306216 Free PMC article.
Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis.
Ye Y, Yin DT, Chen L, Zhou Q, Shen R, He G, Yan Q, Tong Z, Issekutz AC, Shapiro CL, Barsky SH, Lin H, Li JJ, Gao JX. Ye Y, et al. Among authors: shapiro cl. PLoS One. 2010 Oct 20;5(10):e13406. doi: 10.1371/journal.pone.0013406. PLoS One. 2010. PMID: 20975993 Free PMC article.
Histone H1 phosphorylation in breast cancer.
Harshman SW, Hoover ME, Huang C, Branson OE, Chaney SB, Cheney CM, Rosol TJ, Shapiro CL, Wysocki VH, Huebner K, Freitas MA. Harshman SW, et al. Among authors: shapiro cl. J Proteome Res. 2014 May 2;13(5):2453-67. doi: 10.1021/pr401248f. Epub 2014 Apr 7. J Proteome Res. 2014. PMID: 24601643 Free PMC article.
Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.
Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL. Mrózek E, et al. Among authors: shapiro cl. Clin Breast Cancer. 2014 Aug;14(4):228-34. doi: 10.1016/j.clbc.2014.02.005. Epub 2014 Feb 20. Clin Breast Cancer. 2014. PMID: 24703985 Free PMC article. Clinical Trial.
228 results